10Raj SR, Faris PD, Semeniuk L, et al. Rationale for the Assess- ment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5) [ J ]. Am Heart J, 2016,174:89-94.
4Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology ( ESC), European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope ( version 2009) [ J ]. Eur Heart J, 2009,30 ( 21 ) : 2631-2671.
5Sheldon R S, Morillo C A, Krahn A D, et al. Standard- ized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper [ J ]. Can J Cardiol, 2011,27 (2) :246-253.
6Task Force for the Diagnosis and Management of Syncope, Europe- an Society of Cardiology(ESC), European Heart Rhythm Associa- tion(EHRA), et al. Guidelines for the Diagnosis and Management of Syncope (version 2009)[J]. Eur Heart J,2009,30(21) :2631-2671.
7Brignole M, Alboni P, Benditt D G, et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004[J]. Europace, 2004,6(6) :467-537.
8Anon. The European Society of Cardiology Guidelines for the diag- nosis and management of syncope reviewed by angel moya, MD, FESC. Chair of the guideline task force with J. Taylor, MPhil[J]. Eur Heart J,2009,30(21) :2539-2540.
9Grubb B P, Karabin B. Syncope:evaluation and management in the geriatric patient[J]. Clin Geriatr Med, 2012,28 (4):717 - 728.
10Jansen S, Kenny R A, de Rooij S E, et al. Selreported cardiovascu- lar conditions are associated with Jails and syncope in community dwelling older adults[J].Age Ageing, 2009,30 (21) : 2539 - 2540.
